| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Sep 24, 2024 | Buy(P) | 1.6M | — | — | 13.8M |
| Sep 24, 2024 | Buy(P) | 5.4M | — | — | 12.2M |
| Sep 24, 2024 | Buy(P) | 1.2M | — | — | 6.8M |
| Sep 24, 2024 | Buy(P) | 4.8M | — | — | 5.6M |
| Sep 24, 2024 | Buy(P) | 262K | — | — | 818K |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Sep 24, 2024 | Sell(S) | 2.5M | — | — | 0 |
| Sep 24, 2024 | Sell(S) | 524K | — | — | 0 |
| Sep 24, 2024 | Sell(S) | 0 | — | — | 0 |
| Sep 24, 2024 | Sell(S) | 0 | — | — | 0 |
| Sep 24, 2024 | Sell(S) | 3.1M | — | — | 0 |
Parsed from a single SEC EDGAR Form 4/A filing (accession 0001104659-25-045416) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Ernexa Therapeutics Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.